Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Journal of Surgical Oncology|February 1, 1988
Intraperitoneal infusion of 5-FU in liver metastases from colorectal cancerH Ekberg, K G Tranberg, B Persson, et al.
Neurology|April 12, 2006
Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?J Persson, J Lind, A Larsson, et al.
Neuropsychologia|March 19, 2008
Altered deactivation in individuals with genetic risk for Alzheimer's diseaseJ Persson, J Lind, A Larsson, et al.
Inflammatory Bowel Diseases|August 29, 2000
Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupE J Irvine, G R Greenberg, B G Feagan, et al.
Gastroenterology|January 1, 1996
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
The New England Journal of Medicine|September 29, 1994
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
Comprehensive Psychiatry|June 2, 1998
Swedish normative data on personality using the Temperament and Character InventoryS Brändström, P Schlette, T R Przybeck, et al.
Gastroenterology|August 28, 1998
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study groupS B Hanauer, M Robinson, R Pruitt, et al.
Gastroenterology|January 29, 1999
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study GroupG Hellers, A Cortot, D Jewell, et al.
Neurobiology of Aging|May 27, 2005
Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's diseaseR Rademakers, K Sleegers, J Theuns, et al.
Pageof 10